30 August 2022 - final results
THE AIM-listed specialist infection control company has announced its results for the year to 31 March 2022 and these have revealed a return to more normal levels of trading following the upsurge in sales during the Covid pandemic. Sales for the year were £6.3m (2021: £11.2m) although this figure was higher than the £6.0m recorded in the year to 31 March 2020. However, the company has recorded an adjusted pre-tax loss of £0.25m (2021: adjusted pre-tax profit of £1.39m). The company ended the year with net cash . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
